Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Document Security Systems (DSS)

Document Security Systems (DSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,320
  • Shares Outstanding, K 9,092
  • Annual Sales, $ 19,100 K
  • Annual Income, $ -46,900 K
  • EBIT $ -42 M
  • EBITDA $ -39 M
  • 60-Month Beta 1.33
  • Price/Sales 0.45
  • Price/Cash Flow N/A
  • Price/Book 0.29
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -5.46
  • Most Recent Earnings $-0.55 on 05/15/25
  • Next Earnings Date 08/12/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Conglomerates
  • INDUSTRY GROUPING Conglomerates - Div Operations

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7899 +19.27%
on 06/24/25
1.0300 -8.53%
on 06/24/25
-0.0379 (-3.87%)
since 06/18/25
3-Month
0.7200 +30.85%
on 05/07/25
1.0300 -8.53%
on 06/24/25
-0.0451 (-4.57%)
since 04/17/25
52-Week
0.7200 +30.85%
on 05/07/25
1.5800 -40.37%
on 07/19/24
-0.5979 (-38.82%)
since 07/18/24

Most Recent Stories

More News
DSS, Inc.’s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger

DSS : 0.9421 (+2.96%)
DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth

DSS : 0.9421 (+2.96%)
Sentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., Receives FINRA Approval to Act as Underwriter and Selling Group Member for Corporate Securities Offerings

DSS : 0.9421 (+2.96%)
DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth

DSS : 0.9421 (+2.96%)
DSS, Inc. Issues Letter to Shareholders

DSS : 0.9421 (+2.96%)
Insider Purchase: Director at $DSS (DSS) Buys 205,149 Shares

Heng Fai Ambrose Chan, a director at $DSS ($DSS), bought 205,149 shares of the company on 12-10-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased...

DSS : 0.9421 (+2.96%)
DSS Announces Licensing of Impact BioMedical’s Linebacker Portfolio to ProPhase Labs

ROCHESTER, N.Y., July 21, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and...

DSS : 0.9421 (+2.96%)
PRPH : 0.3728 (-0.16%)
DSS Strengthens and Expands Board with Appointment of Two Independent Directors

ROCHESTER, N.Y., July 13, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and...

DSS : 0.9421 (+2.96%)
Impact BioMedical Announces License Agreement with ProPhase Labs to Produce and Distribute Viral-Fighting Compound Equivir

HENRIETTA, N.Y., June 28, 2022 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE American: DSS), along with its...

DSS : 0.9421 (+2.96%)
PRPH : 0.3728 (-0.16%)
DSS’s Impact BioMedical Receives China Patent for its Functional Fragrance Formulation Mosquito Repellant

China is one of the leading markets globally for insect repellants...

DSS : 0.9421 (+2.96%)

Business Summary

DSS Inc. is a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy and securitized digital assets. DSS Inc., formerly known as Document Security Systems Inc., is based in ROCHESTER, N.Y.

See More

Key Turning Points

3rd Resistance Point 1.0067
2nd Resistance Point 0.9883
1st Resistance Point 0.9517
Last Price 0.9421
1st Support Level 0.8967
2nd Support Level 0.8783
3rd Support Level 0.8417

See More

52-Week High 1.5800
Fibonacci 61.8% 1.2515
Fibonacci 50% 1.1500
Fibonacci 38.2% 1.0485
Last Price 0.9421
52-Week Low 0.7200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar